These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34233297)

  • 1. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer.
    Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q
    Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
    Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
    Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
    Front Oncol; 2021; 11():711402. PubMed ID: 34497764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
    Yin Z; Ma T; Chen S; Yu M
    Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
    Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
    Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
    Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
    PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor.
    Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y
    Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
    Li X; Zhong Q; Luo D; Du Q; Liu W
    PLoS One; 2019; 14(4):e0214611. PubMed ID: 30973890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells.
    Zhang Z; Tan X; Luo J; Cui B; Lei S; Si Z; Shen L; Yao H
    Cancer Med; 2018 Nov; 7(11):5611-5620. PubMed ID: 30267476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
    Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
    Lv QY; Zou HZ; Xu YY; Shao ZY; Wu RQ; Li KJ; Deng X; Gu DN; Jiang HX; Su M; Zou CL
    Bioengineered; 2021 Dec; 12(1):3711-3725. PubMed ID: 34269159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer.
    Jing Y; Wang F; Zhang K; Chen Z
    BMC Med Genomics; 2022 Apr; 15(1):96. PubMed ID: 35468838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
    Oladipo O; Conlon S; O'Grady A; Purcell C; Wilson C; Maxwell PJ; Johnston PG; Stevenson M; Kay EW; Wilson RH; Waugh DJ
    Br J Cancer; 2011 Feb; 104(3):480-7. PubMed ID: 21285972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and role of CXC chemokines in colorectal cancer.
    Verbeke H; Struyf S; Laureys G; Van Damme J
    Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma.
    Wang K; Li R; Zhang Y; Qi W; Fang T; Yue W; Tian H
    Int J Gen Med; 2022; 15():2283-2300. PubMed ID: 35250303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.
    Wang J; Zhang C; Chen X; Li Y; Li A; Liu D; Li F; Luo T
    Transl Cancer Res; 2021 May; 10(5):2169-2187. PubMed ID: 35116536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
    Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
    Front Oncol; 2019; 9():1555. PubMed ID: 32117786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.